Piramal Pharma Ltd. - Research Center
543635 PPLPHARMA Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Sales | 2,347.59 | 1,840.67 | 1,575.34 | 1,677.75 | 1,417.20 |
| Operating profit | 404.52 | 102.75 | -19.29 | 241.96 | 155.34 |
| Interest | 54.83 | 62.02 | 48.87 | 31.18 | 22.37 |
| Gross profit | 492.83 | 156.49 | 156.15 | 341.74 | 225.60 |
| EPS (Rs) | 2.23 | 0.33 | 0.25 | 2.01 | 1.05 |
Half yearly
results in details
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Other income | 143.14 | 115.76 | 224.31 | 130.96 | 92.63 |
| Stock adjustment | -203.76 | -76.64 | -16.27 | 37.68 | -67.85 |
| Raw material | 785.98 | 683.09 | 578.73 | 392.52 | 611.16 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 363.68 | 310.49 | 270.20 | 199.18 | 226.12 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 997.17 | 820.98 | 761.97 | 806.41 | 492.43 |
| Provisions made | - | - | - | - | - |
| Depreciation | 105.46 | 101.20 | 91.89 | 57.31 | 73.33 |
| Taxation | 92.04 | 11.49 | 27.09 | 48.34 | 32.84 |
| Net profit / loss | 295.33 | 43.80 | 30.21 | 238.70 | 104.35 |
| Extra ordinary item | - | - | -6.96 | 2.61 | -15.08 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 1,323.14 | 1,322.95 | 1,193.32 | 1,185.91 | 994.60 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 17.23 | 5.58 | -1.22 | 14.42 | 10.96 |
| GPM (%) | 19.79 | 8.00 | 8.68 | 18.89 | 14.94 |
| NPM (%) | 11.86 | 2.24 | 1.68 | 13.20 | 6.91 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis